In Silico Study of Tropical and Synthetic Compounds Targeting Bcl-2 Protein as Breast Cancer Therapeutic Agents: Uji In Silico Interaksi Senyawa Tropis Alami dan Sintetik Terhadap Protein Bcl-2 Sebagai Agen Antikanker Payudara

Stefany Therisia; Masriani Masriani

doi:10.35706/pc.v6i2.13137

Authors

Stefany Therisia Program Studi Pendidikan Kimia Fakultas Keguruan dan Ilmu Pendidikan Universitas Tanjungpura
Masriani Program Studi Pendidikan Kimia Fakultas Keguruan dan Ilmu Pendidikan Universitas Tanjungpura

DOI:

https://doi.org/10.35706/pc.v6i2.13137

Keywords:

Breast cancer, Bcl-2, Molecular docking, Tropical plants, Synthetic compounds

Abstract

Breast cancer remains the leading cause of death among women worldwide. Resistance to chemotherapy and adverse effects of conventional treatments have driven the search for alternative therapeutic agents derived from natural compounds. One of the key molecular targets involved in cancer cell apoptosis is the Bcl-2 protein family. This study aimed to systematically review in silico molecular docking studies of natural compounds from tropical plants and synthetic molecules targeting the Bcl-2 protein as potential therapeutic agents for breast cancer. A total of 21 original research articles published in the last five years were analyzed based on the source of compounds (plant-derived or synthetic), active constituents, protein database (PDB) codes, and binding affinity values. The results indicated that most compounds demonstrated strong inhibitory potential against Bcl-2, with notable examples such as Niaziminin B from Moringa oleifera (−14.96 kcal/mol) showing one of the highest binding affinities. This review highlights the potential of natural compounds from tropical plants and synthetic molecules as promising candidates for breast cancer therapy through Bcl-2 inhibition. Further in vitro and in vivo studies are required to confirm their biological activity and toxicity profiles in the drug development process.

Keywords: Breast cancer; Bcl-2; Molecular docking; Tropical plants; Synthetic compounds.

Downloads

Download data is not yet available.

References

Arsianti, Ade, &nbsp Fadilah, &nbsp Kusmardi, Hiroki Tanimoto, Tsumoru Morimoto, and Kiyomi Kakiuchi. 2019. “Design and Molecular Docking Study of Antimycin A&Lt;Sub&Gt;3&Lt;/Sub&Gt; Analogues as Inhibitors of Anti-Apoptotic Bcl-2 of Breast Cancer.” Open Journal of Medicinal Chemistry 04(03):79–86. doi: 10.4236/ojmc.2014.43006.

Biswas, Pronama, Dishali Mathur, Jinal Dinesh, Hitesh Kumar Dinesh, and Belaguppa Manjunath Ashwin Desai. 2025. “Computational Analysis Using Multi-Ligand Simultaneous Docking of Withaferin A and Garcinol Reveals Enhanced BCL-2 and AKT-1 Inhibition.” Pp. 1–6 in 2025 International Conference on Innovation in Computing and Engineering (ICE). IEEE.

Christina, Yuyun Ika, Wirdatun Nafisah, Mochammad Fitri Atho’illah, Muhaimin Rifa’i, Nashi Widodo, and Muhammad Sasmito Djati. 2021. “Anti-Breast Cancer Potential Activity of Phaleria Macrocarpa (Scheff.) Boerl. Leaf Extract through in Silico Studies.” Journal of Pharmacy & Pharmacognosy Research 9(6):824–45. doi: 10.56499/jppres21.1092_9.6.824.

Frimayanti, Neni, Rahma Dona, and Tabah Solihin. 2023. “Molecular Docking Study of Chalcone Analogue Compounds with Hydroxy and Methoxy Subtituents as Bcl-2 Inhibitors.” Chempublish Journal 7(1):31–41. doi: 10.22437/chp.v7i1.17487.

Gowtham, Hittanahallikoppal Gajendramurthy, Faiyaz Ahmed, Satish Anandan, C. S. Shivakumara, Ashween Bilagi, Sushma Pradeep, Chandan Shivamallu, Ali A. Shati, Mohammad Y. Alfaifi, Serag Eldin I. Elbehairi, Raghu Ram Achar, Ekaterina Silina, Victor Stupin, Mahadevamurthy Murali, and Shiva Prasad Kollur. 2023. “In Silico Computational Studies of Bioactive Secondary Metabolites from Wedelia Trilobata against Anti-Apoptotic B-Cell Lymphoma-2 (Bcl-2) Protein Associated with Cancer Cell Survival and Resistance.” Molecules 28(4):1588. doi: 10.3390/molecules28041588.

Khan, Mohsin Ali, Romila Singh, Sahabjada Siddiqui, Imran Ahmad, Rumana Ahmad, Shivbrat Upadhyay, Md. Abul Barkat, Ahmed Mahmoud Abdelhaleem Ali, Qamar Zia, Aditi Srivastava, Anchal Trivedi, Ishrat Husain, Anand Narain Srivastava, and Durga Prasad Mishra. 2022. “Anticancer Potential of Phoenix Dactylifera L. Seed Extract in Human Cancer Cells and pro-Apoptotic Effects Mediated through Caspase-3 Dependent Pathway in Human Breast Cancer MDA-MB-231 Cells: An in Vitro and in Silico Investigation.” BMC Complementary Medicine and Therapies 22(1):68. doi: 10.1186/s12906-022-03533-0.

Kusmana, Cecep, and Agus Hikmat. 2015. “The Biodiversity of Flora in Indonesia.” Journal of Natural Resources and Environmental Management 5(2):187–98. doi: 10.19081/jpsl.5.2.187.

Massardi, Adhie, Sandy Samsul Bahry, Nur Anindya Rahmawati, Carissa Azmi Shabirah, and Artini Pangastuti. 2023. “Bioactive Compounds from Penicillium Sp. Inhibit Antiapoptotic Bcl-2, Bcl-XL and Mcl-1: An in Silico Study.” Molecular and Cellular Biomedical Sciences 7(2):81. doi: 10.21705/mcbs.v7i2.330.

Mohamad Rosdi, Mohamad Norisham, Shahkila Mohd Arif, Mohamad Hafizi Abu Bakar, Siti Aisyah Razali, Razauden Mohamed Zulkifli, and Harisun Ya’akob. 2018. “Molecular Docking Studies of Bioactive Compounds from Annona Muricata Linn as Potential Inhibitors for Bcl-2, Bcl-w and Mcl-1 Antiapoptotic Proteins.” Apoptosis 23(1):27–40. doi: 10.1007/s10495-017-1434-7.

Nandana, Pandu Ishaq, Haerani Rasyid, Prihantono, Ika Yustisia, and Lukman Hakim. 2023. “Molecular Docking Studies of Brucein D as a Potential Inhibitor of the Bcl-2 Anti-Apoptotic Protein.” Bali Medical Journal 12(2):2148–52. doi: 10.15562/bmj.v12i2.4414.

Narayanan Nair, Dhanya, and S. Padmavathy. 2017. “Molecular Docking Studies of Phytocompounds from Aloe Vera (L.) Burm.f. Having Anticancer Property, against an Antiapoptotic Bcl-2 Protein.” Biosciences, Biotechnology Research Asia 14(4):1449–56. doi: 10.13005/bbra/2590.

Qian, Shanna, Zhong Wei, Wanting Yang, Jinling Huang, Yinfeng Yang, and Jinghui Wang. 2022. “The Role of BCL-2 Family Proteins in Regulating Apoptosis and Cancer Therapy.” Frontiers in Oncology 12. doi: 10.3389/fonc.2022.985363.

RAUF, Abdur, Aniqa ATTA, Umer RASHID, Yahya S. AL-AWTHAN, Omar S. BAHATTAB, Zafar A. SHAH, Muhammad SHAH, Saima NAZ, Zubair AHMAD, Sami SIRAJ, Ishaq KHAN, and Hassan A. HEMEG. 2024. “Anticancer Potential and In-Silico Computational Studies of Bioactive Secondary Metabolites Isolated from Heterophragma Adenophyllum (Wall. Ex G. Don) Steenis.” Minerva Biotechnology and Biomolecular Research 36(2). doi: 10.23736/S2724-542X.24.03089-X.

Ravindra B. Malabadi, Sadiya MR, Kiran P. Kolkar, Simuzar S. Mammadova, Raju K. Chalannavar, and Himansu Baijnath. 2024. “Role of Plant Derived-Medicine for Controlling Cancer.” International Journal of Science and Research Archive 11(1):2502–39. doi: 10.30574/ijsra.2024.11.1.0315.

Safwat, Ghada M., Kamel M. A. Hassanin, Eman T. Mohammed, Essam Kh. Ahmed, Mahmoud R. Abdel Rheim, Mohamed A. Ameen, Mohamed Abdel-Aziz, Ahmed M. Gouda, Ilaria Peluso, Rafa Almeer, Mohamed M. Abdel-Daim, and Ahmed Abdel-Wahab. 2021. “Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone‐Thienopyrimidine Derivatives in HepG2 and MCF‐7 Cell Lines” edited by E. Desideri. Oxidative Medicine and Cellular Longevity 2021(1). doi: 10.1155/2021/4759821.

Saha, Asmita, Belaguppa Manjunath Ashwin Desai, and Pronama Biswas. 2024. “Multi-Ligand Simultaneous Docking Analysis of Moringa Oleifera Phytochemicals Reveals Enhanced BCL-2 Inhibition via Synergistic Action.” Pp. 51–56 in 2024 5th International Conference on Biomedical Engineering (IBIOMED). IEEE.

Sathishkumar, Natarajan, Subramaniyam Sathiyamoorthy, Mathiyalagan Ramya, Dong-Uk Yang, Hee Nyeong Lee, and Deok-Chun Yang. 2012. “Molecular Docking Studies of Anti-Apoptotic BCL-2, BCL-XL, and MCL-1 Proteins with Ginsenosides from Panax Ginseng.” Journal of Enzyme Inhibition and Medicinal Chemistry 27(5):685–92. doi: 10.3109/14756366.2011.608663.

Siddika, Ayesha, Plabon K. Das, Saharia Y. Asha, Suraiya Aktar, Abu R. M. Tareq, Ayesha Siddika, Abdur Rakib, Farhadul Islam, and Jahan Ara Khanam. 2021. “Antiproliferative Activity and Apoptotic Efficiency of Syzygium Cumini Bark Methanolic Extract against EAC Cells In Vivo.” Anti-Cancer Agents in Medicinal Chemistry 21(6):782–92. doi: 10.2174/1871520620666200811122137.

Siegel, Rebecca L., Tyler B. Kratzer, Angela N. Giaquinto, Hyuna Sung, and Ahmedin Jemal. 2025. “Cancer Statistics, 2025.” CA: A Cancer Journal for Clinicians 75(1):10–45. doi: 10.3322/caac.21871.

Smolarz, Beata, Anna Zadrożna Nowak, and Hanna Romanowicz. 2022. “Breast Cancer—Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature).” Cancers 14(10):2569. doi: 10.3390/cancers14102569.

Thoyajakshi, R. S., G. T. Megha, H. Ravi Kumar, Shridhar N. Mathad, Anish Khan, S. Nagaraju, Mohamed H. Mahmoud, and AbuZar Ansari. 2024. “Garcinol: A Novel and Potent Inhibitor of Hyaluronidase Enzyme.” International Journal of Biological Macromolecules 266:131145. doi: 10.1016/j.ijbiomac.2024.131145.

Yap, Kah Min, Mahendran Sekar, Yuan Seng Wu, Siew Hua Gan, Nur Najihah Izzati Mat Rani, Lay Jing Seow, Vetriselvan Subramaniyan, Neeraj Kumar Fuloria, Shivkanya Fuloria, and Pei Teng Lum. 2021. “Hesperidin and Its Aglycone Hesperetin in Breast Cancer Therapy: A Review of Recent Developments and Future Prospects.” Saudi Journal of Biological Sciences 28(12):6730–47. doi: 10.1016/j.sjbs.2021.07.046.